ArticleAnti-cancer drugs2019

Antitumor and immunomodulatory effects of a novel multitarget inhibitor, CS2164, in mouse hepatocellular carcinoma models.

You Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.